Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 831-840 of 2916 for cancer

Edit search filters
  1. IMC-F106C Regimen Versus Nivolumab Regimens In Previously Untreated Advanced Melanoma (PRISM-MEL-301)

    Jacksonville, FL

  2. Gemcitabine And Cisplatin As Neoadjuvant Chemotherapy In Patients With High-Grade Upper Tract Urothelial Carcinoma

    Scottsdale/Phoenix, AZ

  3. Tebentafusp Regimen Versus Investigator's Choice In Previously Treated Advanced Melanoma (TEBE-AM)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Phase 3 Study To Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy In Previously Treated Head And Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study To Evaluate Effectiveness And Safety Of MBG453 In Combination With Azacitidine In Subjects With Intermediate, High Or Very High Risk Myelodysplastic Syndrome (MDS), Or Chronic Myelomonocytic Leukemia-2 (CMML-2)

    Jacksonville, FL

  6. A Study Of MT-0169 In Participants With Relapsed Or Refractory Multiple Myeloma Or Non-Hodgkin Lymphoma

    Jacksonville, FL, Rochester, MN

  7. A Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Fruquintinib In Patients With Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Study To Evaluate Duloxetine To Prevent Oxaliplatin-Induced Peripheral Neuropathy In Patients With Stage II-III Colorectal Cancer

    Eau Claire, WI, Mankato, MN, Rochester, MN

  9. FT576 in Subjects With Multiple Myeloma

    Jacksonville, FL

  10. A Study Evaluating The Efficacy And Safety Of Cevostamab In Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma (CAMMA 2)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer